Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease

Use of proton-pump inhibitors (PPIs) is common in patients with chronic kidney disease (CKD). PPIs and many uremic toxins (UTs) are eliminated by the kidney’s tubular organic anion transporter system. In a cross-sectional study, we sought to evaluate the association between PPI prescription and seru...

Full description

Bibliographic Details
Main Authors: Carolla El Chamieh, Islam Amine Larabi, Solène M. Laville, Christian Jacquelinet, Christian Combe, Denis Fouque, Maurice Laville, Luc Frimat, Roberto Pecoits-Filho, Céline Lange, Bénédicte Stengel, Natalia Alencar De Pinho, Jean-Claude Alvarez, Ziad A. Massy, Sophie Liabeuf
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Toxins
Subjects:
uremic toxins
indoxyl sulfate
proton-pump inhibitor
chronic kidney disease
Online Access:https://www.mdpi.com/2072-6651/15/4/276

Internet

https://www.mdpi.com/2072-6651/15/4/276

Similar Items